Sign in
4/A

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-040099

Chief Scientific Officer sold 7,790 shares at an average $35.56 ($277,048)

  • Chief Scientific Officer acquired 7,790 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-05-05 Option exercise +3,895 $6.32 $24,616 73,255 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-05-05 Sale −3,895 $35.43 $138,000 69,360 D: show line 2 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-05-06 Option exercise +3,895 $6.32 $24,616 73,255 D: show line 3 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-05-06 Sale −3,048 $35.51 $108,234 70,207 D: show line 4 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-05-06 Sale −847 $36.38 $30,814 69,360 D: show line 5 in the form
Open-market sales · 7,790 sh · avg $35.56 · $277,048

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-05-05 Option exercise · Stock Option (Right to Buy) −3,895 132,430 D: show line 6 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-05-06 Option exercise · Stock Option (Right to Buy) −3,895 128,535 D: show line 7 in the form
Loading xslF345X03/doc4a.xml…